Study Implicates Two Genetic Variants in Bicuspid Aortic Valve Development

Researchers report a key protein is affected during heart valve formation, in the first genomewide study of bicuspid aortic valve.

5:00 AM

Author | Haley Otman

Researchers are working to determine why the aortic valve doesn't form correctly in patients with the most common congenital heart defect: bicuspid aortic valve.

MORE FROM THE LAB: Subscribe to our weekly newsletter

In a new Nature Communications study, the Michigan Medicine-led group found two genetic variants associated with the condition.

Bicuspid aortic valve is moderately heritable, yet experts are still figuring out which part of our DNA code explains why some BAV patients inherit the disease.

"We've completed the first successful genomewide study of bicuspid aortic valve, by studying subjects at U-M's Frankel Cardiovascular Center," says first author Bo Yang, M.D., Ph.D., a Michigan Medicine cardiac surgeon. "We are using state-of-the-art technology of induced stem cell and gene editing to dissect the genomic region we found to be associated with BAV. It's a great collaboration that will accelerate our scientific understanding of this disease."

BAV patients have aortic valves with only two leaflets, rather than three, limiting the valve's function as the heart pumps oxygen-rich blood toward the aorta to enrich the body. The condition is associated with various complications, including a narrowed valve (aortic stenosis), a leaky valve (aortic insufficiency or regurgitation), an infection of the valve or an aortic aneurysm.

This finding gives us a great head start toward understanding the mechanism of how a genetic change outside the protein-coding part of the genome can lead to disease.
Cristen Willer, Ph.D.

'A great head start'

The researchers performed genomewide association scans of 466 BAV cases from the Frankel Cardiovascular Center and 4,660 controls from the Michigan Genomics Initiative, with replication on 1,326 cases and 8,103 controls from collaborators at other leading institutions. They also reprogrammed the matured white blood cells to change them back into immortal cells (stem cells) and changed the genetic code of those cells to study the function of the variants they identified through the genomewide association study.

SEE ALSO: Jimmy Kimmel Sheds Light on How Health Policy Affects Children with Congenital Heart Disease

The team reports two genetic variants, both affecting a key cardiac transcription factor called GATA4, reached or nearly reached genomewide significance in BAV. GATA4 is a protein important to cardiovascular development in the womb, and GATA4 mutations have been associated with other cardiovascular defects.

"One of the regions we identify actually changes the protein coded by the gene, and the other likely changes expression levels of GATA4 during valve formation," says senior author Cristen Willer, Ph.D., professor of internal medicine, human genetics and computational medicine and bioinformatics. "Because most genetic variants associated with human disease are in the 99 percent of the genome that doesn't code for proteins, this finding gives us a great head start toward understanding the mechanism of how a genetic change outside the protein-coding part of the genome can lead to disease."

Specifically, the authors point to a disruption during the endothelial-mesenchymal transition, which is a critical step in the development of the aortic valve. Willer and Yang say this study, with support from the Frankel CVC and the Bob and Ann Aikens Aortic Program, adds new knowledge about the mechanism of BAV formation. They plan to continue to study the biological effect of both variants associated BAV in cells and animal models.

Collaborators from a variety of institutions provided replication of the result, including Harvard Medical School, the University of Texas, the Montreal Heart Institute, the Karolinska Institute and Icahn School of Medicine at Mount Sinai.


More Articles About: Lab Report Congenital Heart Disease Valve Disease Cardiovascular: Diseases & Conditions
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories up close doctor in hospital with cardiology close up scans on monitors
Health Lab
Researchers find significant differences in care of life threatening shock after heart attack
A study finds most hospitals don’t see many cardiogenic shock patients. When they do, providers often do not have a standardized way of treating them.
blood vessel up close with red cells and yellow inside
Health Lab
Drug candidate successfully treats atherosclerosis, fatty liver disease in large mammals 
A compound that was previously found to treat severe fatty liver disease also reduces atherosclerosis, a primary driver of cardiovascular death, in non-human primates. The drug candidate was developed at the University of Michigan.
woman touching head talking to front desk person
Health Lab
Cognitive decline comes sooner for people with heart failure
There are over six million Americans with heart failure who are at greater risk of losing their cognitive abilities earlier in life, a study led by University of Michigan suggests. 
hands on book reading
Health Lab
Highly educated people face steeper mental declines after stroke
Stroke survivors who have attended some level of higher education may face even steeper mental declines, according to a study led by Michigan Medicine.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Epigenetics, Inflammation and the Human Immune System
People with diabetes often have a host of other conditions including cardiovascular disease and kidney disease driven by inflammation. On today's episode, we talk with Dr. Katherine Gallagher, professor of surgery, professor of microbiology and immunology, and the Leland Ira Doan Research Professor of Vascular Surgery at U of M, who is looking at how epigenetics - the influence of environmental factors and behaviors impact on gene expression - might explain changes in the immune system in people with cardiovascular disease, diabetes, and other conditions related to inflammation.
boy smiling in red shirt sitting
Health Lab
A heart on Valentines Day: young man with rare disease gets second transplant
A young man from Michigan who was born with the rare disease Barth Syndrome received a new heart over two decades after having a heart transplant as an infant.